Open Access

Buschke‑Löwenstein tumors: A series of 7 case reports

  • Authors:
    • Daniel Boda
    • Ana Cutoiu
    • Dalia Bratu
    • Nona Bejinariu
    • Rodica Crutescu
  • View Affiliations

  • Published online on: April 13, 2022     https://doi.org/10.3892/etm.2022.11320
  • Article Number: 393
  • Copyright: © Boda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Giant condyloma acuminatum (GCA), or Buschke‑Löwenstein tumor (BLT), represents an infrequent sexually transmitted disease (STD), caused by human papillomavirus (HPV), especially genotype 6 or 11. There are numerous risk factors for HPV, such as multiple sexual partners, homosexuality, prostitution, chronic genital infections, as well as the lack of proper hygiene. HPV infection is a field infection, where large areas of cells at a tissue surface are affected by the HPV virus; therefore, once the GCA is excised, treatment of the whole affected genital area needs to be undertaken. The treatment is classified into topical therapy (podophyllin, 5‑FU, radiotherapy, topical photodynamic therapy), excisional therapy (CO2 laser, cryotherapy, electrotherapy, surgery) and immunotherapy (imiquimod). However, the ‘gold standard’ therapy is represented by wide surgical excision without grafting, since it is considered that healing per secundam is an improved approach, because there is no risk of recurrences on fibrotic tissue. A total of 7 cases of the BLT with comorbidities and particularities are presented and it is recommended that it be taken into consideration that the incidence of the disease is increasing, emphasizing the importance of an early diagnosis, as well as an adequate treatment.

Introduction

Giant condyloma acuminatum (GCA), also known as Buschke-Löwenstein tumor (BLT), represents an infrequent sexually transmitted disease (STD) triggered most frequently by HPV (human papilloma virus) 6 and 11(1), and exceptionally 16 and 18 (2,3), having common risk factors with condyloma acuminatum (including multiple partners, prostitution, men having sex with men, poor hygiene as well as other STDs) (1,4,5).

BLT is always preceded by condyloma acuminatum, with certain authors considering that it is the midway between condyloma acuminatum and squamous cell carcinoma, and the malignant transformation risk is 40-60% (4,6). It is associated with the immunosuppressive status: Congenital or acquired immunodeficiencies, diabetes mellitus, alcoholism, chemotherapy, immunosuppressive therapy (7).

BLT may occur at any age, particularly after puberty. Men are more affected than women, usually between 30 and 50 years old, with a male/female sex ratio of 3:1. The general incidence in the US is 0.1%, similar with the one from the developed countries in Europe (4). It is considered that almost everyone will manifest a minimum of one HPV infection during their lifetime, often asymptomatic, transient, spontaneously resolved, without being aware of it and 2% will develop condyloma acuminata (8).

Clinically, it presents as an exophytic, vegetative tumor, frequently cauliflower-like, white-yellowish, slowly or rapidly growing depending on the immune status of the patient, that may invade and destroy the surrounding tissue, without spontaneous resolution (1,9). The risk of distant metastases is low (6). In 81-94% of the cases, the lesion is located on the penis. The anorectal area is affected in 10-17% of the cases and the urethra in 5% of the cases. In females, the vulva is generally the most affected, in 90% of the cases, while the anorectal location is less frequent (4). From a histopathological perspective, the hyperplastic epithelium is well-differentiated, with hyperkeratosis, parakeratosis, koilocytes, a bulging granular layer, papillomatosis and minimal atypia (1,9).

The treatment is classified into topical therapy (podophyllin, 5-FU, radiotherapy), excisional therapy (CO2 laser, cryotherapy, electrotherapy, surgery) and immunotherapy (imiquimod). A rather new therapy to be considered is the photodynamic therapy, that uses aminolevulinic acid hydrochloride; photosensitizers have been revealed to have antiviral action (1). The association with invasive genital carcinoma, as well as its aggressive character, require multidisciplinary collaboration, including colonoscopy for the rectal invasion (10). Selecting the right treatment option depends on the tumor characteristics and on the skills of the physician, with surgical treatment remaining as the first line therapy, with a lower recurrence risk (3,4). If the tumors are invasive, the patients could require a colostomy and nephrostomy (10).

Case reports

Case 1

A 39-year-old male patient with no notable medical history, smoker, and sexual intercourse debut at 15 years old, presented to the Department of Dermatology of Ponderas Academic Hospital for a large exophytic cauliflower-like verrucous tumor in the perianal area and smaller similar lesions localized in the genital, supra-penile, scrotal and crural areas. The patient was negative for STDs and the genotyping was positive for HPV 16. The colonoscopy revealed no rectal invasion and the patient refused a colostomy.

A reduction of the tumor volume was performed with radiosurgical excision under general anesthesia and all the smaller lesions were excised in 10 sessions of CO2 laser under local anesthesia. The histopathological report revealed epidermal hyperplasia, hyperkeratosis, papillomatosis, koilocytes, HPV 6-positive intra-tissue and no signs of malignant transformation.

The healing occurred by secondary intention, in 60 days. The patient received systemic antibiotic therapy with levofloxacin (500 mg/day for 15 days), then cefuroxime (1 g twice a day for 3 weeks), local and intrarectal sinecatechins (twice a day for 4 months), nonspecific immune stimulation with inosine pranobex (3 tablets twice a day for 10 days per month), alternately with Coriolus versicolor (3 tablets twice a day for 4 months). The peniscopy and the microscopic examination of the anogenital region revealed residual subclinical lesions. They were excised with CO2 laser, 3 sessions of fractional photodynamic therapy with 8% levulinic acid applied topically under occlusion for 2 h, then 20 min of 635-nm red light at 70 mJ/cm2 fluency, followed by 10 min of 411-nm blue light at 80 mF/cm2 fluency, and finally 10 min of 635-nm red light at 70 mJ/cm2 fluency. A total of 3 doses of Gardasil vaccine were administered (months 0-2-6) (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6 and Fig. 7).

Case 2

A 26-year-old male homosexual patient, smoker, sexual intercourse debut at 15 years old, and multiple sexual partners, presented to the Department of Dermatology of Ponderas Academic Hospital for a large exophytic cauliflower-like verrucous tumor in the perianal area. The patient had asymptomatic urethral co-infection with Haemophilus influenzae, was negative for STDs and the intra-anal and intra-urethral genotyping was positive for HPV 6 and 16. The colonoscopy revealed no rectal invasion.

The peniscopy and the microscopic examination of the anogenital region revealed 30 subclinical genital, supra-penile and crural lesions, which were excised with CO2 laser in 4 sessions under local anesthesia. The histopathological report revealed epidermal hyperplasia, hyperkeratosis, papillomatosis, koilocytes and HPV 6-positive intra-tissue.

The patient received local and intrarectal sinecatechins (twice a day for 4 months), inosine pranobex (3 tablets twice a day, 10 days per month) alternately with Coriolus versicolor (3 tablets twice a day for 4 months). The peniscopy and the microscopic examination of the anogenital region revealed residual subclinical lesions that were excised with CO2 laser, 3 sessions of fractional photodynamic therapy with 8% levulinic acid applied topically under occlusion for 2 h, then 20 min of 635-nm red light at 70 mJ/cm2 fluency, followed by 10 min of 41-nm blue light at 80 mF/cm2 fluency, and finally 10 min of 635-nm red light at 70 mJ/cm2 fluency. A total of 3 doses of Gardasil vaccine were administered (months 0-2-6) (Fig. 8, Fig. 9, Fig. 10, Fig. 11 and Fig. 12).

Case 3

A 24-year-old male patient, smoker, and sexual intercourse debut at 14 years, consulted us at the Deparment of Dermatology of Ponderas Academic Hospital for a vegetative, exophytic, intra-urethral tumor. The patient had asymptomatic urethral co-infection with Ureaplasma urealiticum and Klebsiella pneumoniae. The intra-urethral genotyping was positive for HPV 16 and 52.

The peniscopy and the microscopic examination of the anogenital region revealed 10 subclinical genital lesions and 15 subclinical lesions supra-penile and perigenital, which were excised in one session of CO2 laser under local anesthesia.

The patient received systemic antibiotherapy with levofloxacin (500 mg/day for 30 days), meloxicam (15 mg/day for 30 days), Sunvert (1 tablet twice a day for 60 days), local and intrarectal sinecatechins (twice a day for 4 months), inosine pranobex (3 tablets twice a day for 10 days per month), alternately with Coriolus versicolor (3 tablets twice a day for 4 months). The peniscopy and the microscopic examination of the anogenital region revealed residual subclinical lesions, which were excised with CO2 laser, 2 sessions of fractional photodynamic therapy with 8% levulinic acid applied topically under occlusion for 2 h, then 20 min of 635-nm red light at 70 mJ/cm2 fluency, followed by 10 min of 411-nm blue light at 80 mF/cm2 fluency, and finally 10 min of 635-nm red light at 70 mJ/cm2 fluency. A total of 3 doses of Gardasil vaccine were administered (months 0-2-6) (Fig. 13).

Case 4

A 32-year-old uncircumcised male patient presented to the Department of Dermatology of Ponderas Academic Hospital for multiple, giant flesh-colored, cauliflower-like growths involving the penis, the supra-penile and the right inguinal region. The patient denied experiencing pain, bleeding or dysuria. The patient had been sexually active since 16 years old and provided history of multiple sexual partners. Laboratory tests were performed in order to verify the status of the patient for STDs and the patient tested positive for an asymptomatic urethral coinfection with Mycoplasma hominis. The HPV genotyping revealed HPV 6, 11 and 54.

The treatment consisted of 5 sessions of CO2 laser with local anesthesia, followed by 2 daily applications of sinecatechins ointment for 4 consecutive months in the affected areas. In addition, the patient was prescribed inosine pranobex (500 mg x 6/day, 10 days/month for 4 months), alternating with Coriolus versicolor (6 cps/day 20 days/month for 4 months). The patient was advised to get vaccinated against HPV with 3 shots of Gardasil 9 vaccine.

At the follow-up visit, the microscopic analysis of the genital skin revealed certain persistent subclinical lesions, for which the patient underwent 2 sessions of topical photodynamic therapy. Briefly, 8% aminolevulinic acid (ALA) was applied and after 2 h, the dressing was removed and the lesions were irradiated using a red light for 20 min (the peak emission of 635 nm was used and the total dose was 70 mJ/cm2), then a blue light was used for another 10 min (80 mJ/cm2), followed again by a red light (635 nm, 70 mJ/cm2) (Fig. 14, Fig. 15 and Fig. 16).

Case 5

An 18-year-old bisexual man presented to the Department of Dermatology of Ponderas Academic Hospital for a giant, indurated, flesh-colored, cauliflower-like tumor mass around the anus and certain other small lesions dispersed on the suprapubic area and around the penis. The patient had been recently diagnosed with HIV, and had been started on antiretroviral therapy. STD screening was positive for syphilis, Ureaplasma urealyticum, Mycoplasma hominis and Candida. The colonoscopy revealed no rectal invasion and the patient refused a colostomy.

The tumor was excised with radiosurgery under general anesthesia and all the smaller lesions were excised in 1 session of CO2 laser under local anesthesia. A biopsy was sent to the pathologist.

The healing occurred by secondary intention, in 60 days. The patient received systemic antibiotic therapy with gentamicin (80 mg every 12 h), benzathine benzylpenicillin (2.4 MUI/week for 10 weeks) for the syphilitic infection, doxycycline (100 mg 2 tablets/day for 30 days), fluconazole (50 mg 1 tablet/day for 30 days), local and intrarectal sinecatechins (twice a day for 4 months), inosine pranobex (3 tablets twice a day, 10 days per month), alternately with Coriolus versicolor (3 tablets twice a day for 4 months) and was administered 3 doses of Gardasil 9 vaccine (months 0-2-6) (Fig. 17, Fig. 18 and Fig. 19).

Case 6

A 34-year-old smoking woman presented to the Department of Dermatology of Ponderas Academic Hospital for a giant, indurated, flesh-colored, cauliflower-like tumor mass involving the vulvar area and certain verrucous papules distributed over the suprapubic area and buttocks. The medical history revealed that the patient had been HIV-positive for 23 years due to an erroneous blood transfusion (CD4 count, 750 cells/mm3). The patient tested positive for HPV 16, 18, 39, 6, 11 and 53 genotypes. The biopsy revealed poorly differentiated squamous cell carcinoma (T4N2MXV0L1). The patient underwent pelvectomy with nephrostomy, followed by localized radiotherapy (Figs. 20 and 21).

Case 7

A 75-year-old female patient presented to the Department of Dermatology of Ponderas Academic Hospital for an indurated tumor mass located in the vulvar area. The lesion had been growing progressively for numerous years. The PCR test conducted on the vaginal brushing revealed the presence of HPV 6, 16 and 18. The tumor was excised with radiosurgery under general anesthesia. The biopsy of the lesion identified HPV 6 and 16 genotypes and revealed moderately differentiated squamous cell carcinoma. Therefore, the patient underwent pelvectomy with nephrostomy, followed by radiotherapy (Fig. 22).

Discussion

In 1925, Buschke and Löwenstein described BLT for the first time. They examined a penile lesion, which resembled both common condyloma acuminata and squamous cell carcinoma from a clinical point of view; however, it presented differences from both of these diseases concerning the biological behavior and the histopathological findings (9).

BLT represents an infrequent STD, caused by HPV, mostly genotype 6 or 11. There are numerous risk factors for HPV, such as multiple sexual partners, homosexuality, prostitution, chronic genital infections, as well as the lack of proper hygiene (4,9).

BLT is invariably preceded by condyloma acuminatum and it is more common in individuals with a suppressed immune system caused by AIDS, chemotherapy with immunosuppressive therapy alcoholism or diabetes. HPV screening for HIV-positive and immunocompromised patients should always be a priority in this category of patients (1,4).

A high prevalence of GCA has been reported in the homosexual and bisexual communities. Recurrent aggressive GCA has been reported in HIV-positive patients. BLT could occur at any age, particularly following puberty. However, the elderly should also be tested for HPV infection. Men are more affected than women, and the main affected areas are the penis, the anorectal area and the urethra in males, and the vulva in females (4,11).

From a clinical view, it presents as a voluminous cauliflower-like, flesh-colored tumor of papillomatous and irregular surface, ultimately surpassing 10 cm2 in size (4).

From a histopathological point of view, BLT is characterized by papillomatosis and severe acanthosis. Generally, the hyperplastic epithelium is well-differentiated; nevertheless, the vacuolated epidermal cells reveal clear cytoplasm and hyperchromatic nuclei. The basal membrane is undamaged and there is a lymphohistiocytic inflammatory infiltrate present in the upper dermis. When a biopsy is performed, it should be deep enough to contain the whole tumor, particularly the epidermal/dermal interface (4).

The multiplication cycle of HPV needs stratified squamous epithelium (the junction between it and the columnar or cuboid epithelium being the election site), explaining the HPV-associated cancers on the lips, oral cavity, cervix, prostate, penis, scrotum and rectum. The first structure infected is the basal keratinocyte nucleus and if the host defense mechanism is overcome, the virus multiplies and the DNA copies, during cell division, are distributed to daughter cells, which are hard to identify if the viral gene expression is low. The risk of malignant transformation of infected cells is high if the infection persists more than 6 months; however, ~90% of the cases have a self-limited evolution of 2 years. There are numerous co-factors participating in HPV-related carcinogenesis. The oncogenes E6 and E7 are the key viral oncogenes from HPV 16 and other high-risk HPVs that inactivate p53 and members of the retinoblastoma protein family leading to inhibition of apoptosis, progression of the cellular cycle and accumulation of genetic alterations, viral integration and uncontrolled cell proliferation. The tumor-induced inflammation promotes the proliferation, the survival of the malignant cells and the alteration of the response to chemotherapy. The HPV infection requires either intact skin tissue or wound healing and an active inflammatory process in the skin in order to multiply. This theory has a great impact on the treatment plan, healing per secundam being an improved approach in comparison with grafting after excision, since there is no risk for recurrences on fibrotic tissue (as aforementioned HPV requires stratified squamous epithelium for replication) (12-14).

The main differential diagnoses include Bowen's disease (its dyskeratotic condylomatous form), squamous cell carcinoma, as well as keratotic pseudoepitheliomatous balanitis (4).

It is very difficult to differentiate between BLT and verrucous carcinoma. There are authors who consider these lesions to have numerous similarities. Nevertheless, other authors have strongly suggested that BLT is the midway lesion between condyloma acuminatum and verrucous carcinoma, considering it a condyloma-like precancerous lesion (4).

The most frequent complications of BLT include superinfection, fistulae or necrosis (15). Spontaneous regression is extremely rare, while recurrence following an incomplete excision is very frequent. In the case of GCA, histology does not reveal any evidence of malignancy, such as infiltration of the basement membrane, lymphatic invasion, angioinvasion or distant metastases. Bleeding, infiltration of the tumor basis or lymph node enlargement may lead to the suspicion of a malignant transformation into micro-invasive carcinoma or into well-differentiated squamous cell carcinoma, occurring in 30-50% of the cases (4,5,15).

The incidence of perianal GCA has slightly increased during the last few years, but it remains very hard to differentiate GCA from common condylomas or well-differentiated squamous cell carcinomas. There is a well-known association between HPV 16, 18, 31 and 33 and anogenital squamous cell carcinoma (5,16).

Numerous factors need to be considered when deciding on the most appropriate type of treatment, such as the size, the location of the giant condyloma, as well as previous therapies that have proven unsuccessful. The microscopic analysis of the genital skin for subclinical HPV lesions has a crucial role for an early detection of HPV lesions or recurrences and for selecting the best treatment plan (8).

The ‘gold standard’ therapy is represented by surgical treatment, which consists of full thickness excision and tumor-free margin control. According to the clinical condition of the patient, extensive abdominopelvic surgery may be recommended in cases of visceral involvement.

Preoperative imagistic investigations (CT and MRI) are required before surgery in order to assess the extensiveness of local and systemic disease, and to select the optimal treatment approach. Temporary colostomy followed by reintegration in cases of rectum involvement is also recommended. Despite the fact that numerous authors consider wide local excision followed by split-thickness skin grafts the mainstay of therapy, it is considered that healing per secundam is an improved approach, since grafting represents a risk factor for HPV (6-8).

HPV infection is a field infection, where large areas of cells at a tissue surface are affected by the HPV virus; therefore, once the GCA is excised, focus on treating the whole affected genital area is required. In literature, certain treatment methods for BLT are stated, but the risk of recurrence is very high (podophyllotoxin, usually used for common condyloma acuminata; 5-FU, with improved results for the intraurethral BLT; imiquimod, very aggressive therapy with numerous side effects; cryotherapy, CO2 laser and sinecatechins, very effective with less side effects; and topical photodynamic therapy using both red and blue lights, which was successfully used in our cases) (11,17). However, the best specific immunostimulation is the HPV vaccination with Gardasil 9. In case of verrucous carcinoma, chemotherapy needs to be added to the treatment plan. Radiotherapy, however, appears to be responsible for the alteration of BLT into anaplastic carcinoma (8,18).

In conclusion, despite the fact that numerous authors consider wide local excision followed by split-thickness skin grafts the mainstay of therapy, it is considered in the present study that healing per secundam is an improved approach, since there is no risk for recurrences on fibrotic tissue. For an improved understanding of this phenomenon, further studies are required.

Microscopic analysis of the genital skin for subclinical HPV lesions has a crucial role for an early detection of HPV lesions/recurrences and an improved outcome for the health and social life of the patient.

In case of BLT, there are cases that exceed the qualifications of the dermatologist; therefore, there may be a need for a multidisciplinary approach: Colonoscopy/proctoscopy for rectal invasion, cystoscopy and gynecological exam. The importance of gynecological examination and HPV screening for every female patient should not be overlooked, regardless of age (case 7), nor the importance of HPV screening for HIV-positive and immunocompromised patients (cases 5 and 6) (17,19).

Most importantly, a set of complete STD tests should be performed for all young male patients, as well as smokers and patients who have started their sexual activities early in life. In addition, non-specific immune stimulation and HPV vaccination with Gardasil 9 should be integrated in the treatment plan for every patient with an HPV infection.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors' contributions

DBo performed the biopsies, the CO2 laser excisions, the topical photodynamic therapy and participated in the therapeutic management of the cases. AC and DBr performed the photo documentation of the cases and performed critical review of the literature findings. NB performed the histopathologic examination. RC performed the wide local excision of the lesions. DBo and AC confirm the authenticity of all the raw data. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

A written informed consent for clinical examination, surgery, treatment and obtaining images for publication was obtained from the patients.

Competing interests

The authors declare that they have no competing interests.

References

1 

Chu GY, Chang TCC and Chang CH: Buschke-Löwenstein tumor (giant condyloma acuminatum) successfully treated by topical PDT: A case report. Dermatol Sin. 31:94–97. 2013.

2 

Indinnimeo M, Impagnatiello A, D'Ettorre G, Bernardi G, Moschella CM, Gozzo P, Ciardi A, Bangrazi C, De Felice F, Musio D and Tombolini V: Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: Report of three cases. World J Surg Oncol. 11(231)2013.PubMed/NCBI View Article : Google Scholar

3 

Martin JM, Molina I, Monteagudo C, Marti N, Lopez V and Jorda E: Buschke-Lowenstein tumor. J Dermatol Case Rep. 2:60–62. 2008.PubMed/NCBI View Article : Google Scholar

4 

Hicheri J, Jaber K, Dhaoui MR, Youssef S, Bouziani A and Doss N: Giant condyloma (Buschke-Löwenstein tumor). A case report. Acta Dermatovenerol Alp Pannonica Adriat. 15:181–183. 2006.PubMed/NCBI

5 

Ahsaini M, Tahiri Y, Tazi MF, Elammari J, Mellas S, Khallouk A, El Fassi MJ, Farih MH, Elfatmi H, Amarti A and Stuurman-Wieringa RE: Verrucous carcinoma arising in an extended giant condyloma acuminatum (Buschke-Löwenstein tumor): A case report and review of the literature. J Med Case Rep. 7(273)2013.PubMed/NCBI View Article : Google Scholar

6 

Papiu HS, Dumnici A, Olariu T, Onita M, Hornung E, Goldis D, Aiordachioae G and Vasca V: Perianal giant condyloma acuminatum (Buschke-Löwenstein tumor). Case report and review of the literature. Chirurgia (Bucur). 106:535–539. 2011.PubMed/NCBI

7 

Spinu D, Rădulescu A, Bratu O, Checheriţă IA, Ranetti AE and Mischianu D: Giant condyloma acuminatum-Buschke-Lowenstein disease-a literature review. Chirurgia (Bucur). 109:445–450. 2014.PubMed/NCBI

8 

Tripoli M, Cordova A, Maggì F and Moschella F: Giant condylomata (Buschke-Löwenstein tumours): Our case load in surgical treatment and review of the current therapies. Eur Rev Med Pharmacol Sci. 16:747–751. 2012.PubMed/NCBI

9 

Agarwal S, Nirwal GK and Singh H: Buschke-Lowenstein tumour of glans penis. Int J Surg Case Rep. 5:215–218. 2014.PubMed/NCBI View Article : Google Scholar

10 

De Toma G, Cavallaro G, Bitonti A, Polistena A, Onesti MG and Scuderi N: Surgical management of perianal giant condyloma acuminatum (Buschke-Löwenstein tumor). Report of three cases. Eur Surg Res. 38:418–422. 2006.PubMed/NCBI View Article : Google Scholar

11 

Iorga L, Dragos Marcu R, Cristina Diaconu C, Maria Alexandra Stanescu A, Pantea Stoian A, Liviu Dorel Mischianu D, Surcel M, Bungau S, Constantin T, Boda D, et al: Penile carcinoma and HPV infection (Review). Exp Ther Med. 20:91–96. 2020.PubMed/NCBI View Article : Google Scholar

12 

Lehn H, Ernst TM and Sauer G: Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Löwenstein tumours. J Gen Virol. 65 (Pt 11):2003–2010. 1984.PubMed/NCBI View Article : Google Scholar

13 

Boshart M and zur Hausen H: Human papillomaviruses in Buschke-Löwenstein tumors: Physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol. 58:963–966. 1986.PubMed/NCBI View Article : Google Scholar

14 

Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE, Voiculescu V, et al: Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol. 52:637–655. 2018.PubMed/NCBI View Article : Google Scholar

15 

Neagu M, Caruntu C, Constantin C, Boda D, Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin carcinogenesis: Updates in experimental models (Review). Oncol Rep. 35:2516–2528. 2016.PubMed/NCBI View Article : Google Scholar

16 

Boda D, Neagu M, Constantin C, Voinescu RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D and Tsatsakis AM: HPV strain distribution in patients with genital warts in a female population sample. Oncol Lett. 12:1779–1782. 2016.PubMed/NCBI View Article : Google Scholar

17 

Boda D, Negrei C, Arsene AL, Caruntu C, Lupuleasa D and Ion RM: Spectral and photochemical properties of hyperbranched nanostructures based on gardiquimod and TPPS4. Farmacia. 63:218–223. 2015.

18 

Sandhu R, Min Z and Bhanot N: A gigantic anogenital lesion: Buschke-lowenstein tumor. Case Rep Dermatol Med. 2014(650714)2014.PubMed/NCBI View Article : Google Scholar

19 

Caruntu C, Zurac SA, Jugulete G and Boda D: Extramammary Paget's disease in an HIV-positive patient. Rom J Morphol Embryol. 58:1009–1015. 2017.PubMed/NCBI

Related Articles

Journal Cover

June-2022
Volume 23 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Boda D, Cutoiu A, Bratu D, Bejinariu N and Crutescu R: Buschke‑Löwenstein tumors: A series of 7 case reports. Exp Ther Med 23: 393, 2022
APA
Boda, D., Cutoiu, A., Bratu, D., Bejinariu, N., & Crutescu, R. (2022). Buschke‑Löwenstein tumors: A series of 7 case reports. Experimental and Therapeutic Medicine, 23, 393. https://doi.org/10.3892/etm.2022.11320
MLA
Boda, D., Cutoiu, A., Bratu, D., Bejinariu, N., Crutescu, R."Buschke‑Löwenstein tumors: A series of 7 case reports". Experimental and Therapeutic Medicine 23.6 (2022): 393.
Chicago
Boda, D., Cutoiu, A., Bratu, D., Bejinariu, N., Crutescu, R."Buschke‑Löwenstein tumors: A series of 7 case reports". Experimental and Therapeutic Medicine 23, no. 6 (2022): 393. https://doi.org/10.3892/etm.2022.11320